Rare diseases
Investigational molecules
Locations
Back to Germany4 clinical trials in Cloppenburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on hyperlipoproteinemia and cardiovascular disease management through advanced therapeutic approaches. Research evaluates long-term safety and effectiveness of treatments for patients requiring lipoprotein apheresis.
These trials aim to improve treatment options for patients with elevated lipoprotein levels and established cardiovascular conditions.
Groundbreaking research investigating treatments for IgA Nephropathy, focusing on preventing progressive loss of renal function. The studies evaluate novel therapeutic approaches for managing proteinuria in affected patients.
Clinical investigations aim to advance treatment options for patients with kidney disorders through targeted therapeutic approaches.
Comprehensive evaluation of therapeutic interventions across multiple medical conditions, with a focus on long-term safety profiles and treatment effectiveness. Studies include both controlled trials and extension phases.
Research efforts are directed at optimizing treatment protocols and improving patient care standards.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
